Kringles of the plasminogen--prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site.

Monoclonal antibodies directed against recombinant apolipoprotein (a) (r-apo(a)) lacking plasminogen-like KIV-2 repeats were used to identify structurally related conformational epitopes in various members of the plasminogen-prothrombin gene family. A number of procedures including a fibrin-binding inhibition immunoassay and surface plasmon resonance studies were used. Two antibodies (A10.1 and A10.4) recognised common conformational structures in r-apo(a), prothrombin, factor XII, plasminogen and its tissue-type and urokinase-type activators. In contrast, two other antibodies recognised specifically an epitope comprising residues of the lysine-binding site (A10.2) or close to it (A10.5) and inhibited the fibrin-binding function of r-apo(a) (IC(50)=36 pmol/l and 9.76 nmol/l, respectively). Interestingly, these antibodies distinctly recognised the elastase-derived fragments of plasminogen K4 (A10.2) and K1+2+3 (A10.5) without affecting plasminogen binding to fibrin. These results suggest that highly conserved conformational regions are common to various proteins of the plasminogen-prothrombin gene family and are in agreement with the concept that these proteins constitute a monophyletic group derived from an ancestral gene.

[1]  M. Alessi,et al.  Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.

[2]  M. Koschinsky,et al.  Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. , 1992, Biochemistry.

[3]  R. Breuer,et al.  Book-Review - Contact with the Stars - the Search for Extraterrestrial Life , 1982 .

[4]  E. Angles-cano,et al.  A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping. , 1999, Journal of lipid research.

[5]  L. Hervio,et al.  Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site. , 1999, Biochimica et biophysica acta.

[6]  E. Angles-cano,et al.  Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. , 1991, Biochemistry.

[7]  L. Patthy.  Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules , 1985, Cell.

[8]  T. Blundell,et al.  Molecular evolution and domain structure of plasminogen‐related growth factors (HGF/SF and HGF1/MSP) , 1994, Protein science : a publication of the Protein Society.

[9]  G. Utermann,et al.  Lp(a) Phenotyping by Immunoblotting with Polyclonal and Monoclonal Antibodies , 1988, Arteriosclerosis.

[10]  G. Michiels,et al.  Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. , 1989, Clinical chemistry.

[11]  A. Hughes.  Modes of evolution in the protease and kringle domains of the plasminogen-prothrombin family. , 2000, Molecular phylogenetics and evolution.

[12]  L. Hervio,et al.  Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis , 1993 .

[13]  C. Jenkin,et al.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. , 1978, Immunochemistry.

[14]  P. Cacoub,et al.  Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases. , 2001, The Journal of rheumatology.

[15]  W. Kohr,et al.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[17]  L. Hervio,et al.  Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis. , 1995, Biochemistry.

[18]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[19]  V. Armstrong,et al.  Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. , 1990, Journal of lipid research.

[20]  C. Soria,et al.  Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin. , 1984, Thrombosis research.

[21]  J. Grimbergen,et al.  The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[22]  E. Angles-cano,et al.  Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: An in vitro study using plasma from children with idiopathic nephrotic syndrome. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[23]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[24]  L. Sorell,et al.  A sandwich ELISA based on anti-apo(a) and anti-apo B monoclonal antibodies for lipoprotein(a) measurement. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[25]  G. Utermann,et al.  The Number of Identical Kringle IV Repeats in Apolipoprotein(a) Affects Its Processing and Secretion by HepG2 Cells* , 1996, The Journal of Biological Chemistry.

[26]  Y. Sultan,et al.  A solid-phase fibrin immunoassay for the specific detection of monoclonal antibodies against different epitopic determinants of tissue-plasminogen activators. , 1984, Journal of immunological methods.

[27]  W. C. Breckenridge,et al.  Characterization of monoclonal antibodies to apolipoprotein (a) and development of a chemiluminescent assay for phenotyping apolipoprotein (a) isomorphs. , 1994, Journal of immunological methods.

[28]  G. Luc,et al.  A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB. , 1989, Journal of lipid research.

[29]  A. Salamon,et al.  Immunochemistry of human Lp[a]: characterization of monoclonal antibodies that cross-react strongly with plasminogen. , 1991, Journal of lipid research.

[30]  D. Scheidegger,et al.  Production of monoclonal antibodies: strategy and tactics. , 1980, Journal of immunological methods.

[31]  A. Tulinsky,et al.  Comparison of ligand-binding sites of modeled apo[a] kringle-like sequences in human lipoprotein[a]. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  L. A. Kazal,et al.  The Preparation and Some Properties of Fibrinogen Precipitated from Human Plasma by Glycine.∗ , 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[33]  B. Bouma,et al.  Lysine-Binding Heterogeneity of Lp(a): Consequences for Fibrin Binding and Inhibition of Plasminogen Activation , 1992, Thrombosis and Haemostasis.

[34]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[35]  G. Lippi,et al.  Lipoprotein(a) immunoassays: comparison of a semi-quantitative latex method and two monoclonal enzyme immunoassays , 1995, International journal of clinical & laboratory research.

[36]  Z. Váli,et al.  Location of the intermediate and high affinity omega-aminocarboxylic acid-binding sites in human plasminogen. , 1982, The Journal of biological chemistry.

[37]  D. Belin,et al.  The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.

[38]  A. Bezeaud,et al.  Quantitation of prothrombin activation products in human urine , 1984, British journal of haematology.